Venker Ericinsider trades
In SEC Form 4 filings, Venker Eric is listed as President & Immunovant CEO of Roivant Sciences Ltd. (ROIV) and Chief Executive Officer of Immunovant, Inc. (IMVT). In the last 90 days, Venker Eric sold $21.62M across 2 companies on the open market and bought none. 5 of the 6 sales were reported under a 10b5-1 trading plan.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ROIVRoivant Sciences Ltd. | Oct 20 | Oct 22 | S | 185,856 | $35.09 | Sale −$6,521,687 | 1,413,298 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Oct 20 | Oct 22 | S | 14,144 | $35.42 | Sale −$500,980 | 1,399,154 | Yes | Form 4 |
| IMVTImmunovant, Inc. | Oct 2 | Oct 5 | S | 3,506 | $34.11 | Sale −$119,590 | 257,075 | No | Form 4 |
| IMVTImmunovant, Inc. | Oct 1 | Oct 5 | M | 92,187 | $14.46 | $1,333,024 | 346,467 | No | Form 4 |
| IMVTImmunovant, Inc. | Oct 1 | Oct 5 | D | 85,886 | $33.65 | $2,890,064 | 260,581 | No | Form 4 |
| IMVTImmunovant, Inc. | Oct 1 | Oct 5 | M · derivative | 92,187 | $14.46 | $1,333,024 | 921,875 | No | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 30 | Oct 2 | M | 200,000 | $3.85 | $770,000 | 1,799,154 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 30 | Oct 2 | S | 200,000 | $36.62 | Sale −$7,324,000 | 1,599,154 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 30 | Oct 2 | M · derivative | 200,000 | $3.85 | $770,000 | 3,644,834 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Aug 28 | Sep 1 | M | 200,000 | $3.85 | $770,000 | 1,799,154 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Aug 28 | Sep 1 | S | 166,182 | $35.63 | Sale −$5,921,065 | 1,632,972 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Aug 28 | Sep 1 | S | 33,818 | $36.44 | Sale −$1,232,328 | 1,599,154 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Aug 28 | Sep 1 | M · derivative | 200,000 | $3.85 | $770,000 | 3,844,834 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Aug 20 | Aug 24 | F | 13,909 | $36.84 | $512,408 | 1,599,154 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.